Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Window Therapeutics LLC
Profile last edited on: 3/3/2023      CAGE: 8PJX8      UEI: JFLXDJ3ZY975

Business Identifier: Discovering and developing transformational therapeutics to address critical unmet patient needs in cancer and other life-threatening diseases
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

100 Morrissey Boulevard Room 010-3-187
Boston, MA 02125
   (617) 287-5791
   info@windowtx.com
   www.windowtx.com
Location: Single
Congr. District: 08
County: Suffolk

Public Profile

Window Therapeutics, Inc. discovers and develops transformational therapeutics to address critical unmet patient needs in cancer and other life-threatening diseases through the application of its proprietary Brush-Analogue Macromolecule (BAM) technology.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$256,000
Phase II Dollars
$0
Total Awarded
$256,000

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 1 NSF $256,000
Project Title: Antibody Brush Polymer Conjugates with High Drug Antibody Ratios and Immunostimulatory Payloads for Treatment of Late-Stage Cancers
0 1 NIH $299,999
Project Title: Proteasome Inhibitor-Loaded Antibody Drug Conjugates with High Drug Loading For Targeted Treatment of Triple Negative Breast Cancers

Key People / Management

  Chih-Kao Hu -- Interim CEO and Director

  Kenneth C Anderson -- Director

  Sujuan Ba -- Advisor

  Lawrence Dick -- Advisor

  Yivan Jiang -- Co-Founder & Director, Manufacturing Development

  Jeremiah Johnson -- Co-Founder Chair – Scientific Advisory Board Director

  Raju Kucherlapati -- Advisor

  James Lu -- Director

  Hung Nguyen -- Co-Founder & Director, Therapeutics Development

Company News

There are no news available.